NIP
Nicholas Investment Partners Portfolio holdings
AUM
$1.12B
This Quarter Return
+0.75%
1 Year Return
+50.66%
3 Year Return
+286.38%
5 Year Return
+525.06%
10 Year Return
+2,262.45%
AUM
$1.34B
AUM Growth
+$1.34B
(-8.4%)
Cap. Flow
-$69M
Cap. Flow
% of AUM
-5.16%
Top 10 Holdings %
Top 10 Hldgs %
26.37%
Holding
218
New
22
Increased
46
Reduced
51
Closed
31
Top Buys
| 1 |
Immunocore
IMCR
|
$26.4M |
| 2 |
Sarepta Therapeutics
SRPT
|
$22.8M |
| 3 |
BWX Technologies
BWXT
|
$17.8M |
| 4 |
CBAY
Cymabay Therapeutics
CBAY
|
$17M |
| 5 |
Immunovant
IMVT
|
$14.5M |
Top Sells
| 1 |
Apellis Pharmaceuticals
APLS
|
$37.8M |
| 2 |
Inspire Medical Systems
INSP
|
$37.4M |
| 3 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$35.7M |
| 4 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$19.3M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$17.2M |
Sector Composition
| 1 | Healthcare | 52.08% |
| 2 | Technology | 13.86% |
| 3 | Industrials | 8.87% |
| 4 | Energy | 5.36% |
| 5 | Financials | 5.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
argenx
ARGX
$43.6B
| $46M | 3.44% | 93,566 -1,848 | -2% | -$909K |
|
2
Krystal Biotech
KRYS
$4.27B
| $41.3M | 3.08% | 355,611 -19,340 | -5% | -$2.24M |
|
3
Legend Biotech
LEGN
$6.41B
| $39.8M | 2.97% | 593,010 -157 | -0% | -$10.5K |
|
4
Mirum Pharmaceuticals
MIRM
$3.71B
| $37.9M | 2.83% | 1,199,366 +284,247 | +31% | +$8.98M |
|
5
Roivant Sciences
ROIV
$8.15B
| $35M | 2.62% | 2,998,135 +732,812 | +32% | +$8.56M |
|
6
Vertex Pharmaceuticals
VRTX
$100B
| $33M | 2.46% | 94,758 +14,642 | +18% | +$5.09M |
|
|
IMGN
7
DELISTED
Immunogen Inc
IMGN
| $32.8M | 2.45% | 2,067,561 +843,434 | +69% | +$13.4M |
|
8
Establishment Labs
ESTA
$1.2B
| $30.5M | 2.27% | 620,622 +84,607 | +16% | +$4.15M |
|
9
Xenon Pharmaceuticals
XENE
$2.98B
| $29.2M | 2.18% | 854,447 +63,329 | +8% | +$2.16M |
|
10
Cytokinetics
CYTK
$4.23B
| $27.8M | 2.07% | 942,137 +259,270 | +38% | +$7.64M |
|
11
Axsome Therapeutics
AXSM
$6.05B
| $27.6M | 2.06% | 394,980 +96 | +0% | +$6.71K |
|
|
CBAY
12
DELISTED
Cymabay Therapeutics
CBAY
| $27.4M | 2.05% | 1,840,014 +1,143,067 | +164% | +$17M |
|
13
Day One Biopharmaceuticals
DAWN
$769M
| $26.9M | 2.01% | 2,188,654 -48,457 | -2% | -$595K |
|
|
14
Immunocore
IMCR
$1.62B
| $26.6M | 1.99% | 512,855 +508,155 | +10,812% | +$26.4M |
|
15
Merck
MRK
$210B
| $25.2M | 1.88% | 244,934 | – | – |
|
16
Vaxcyte
PCVX
$4B
| $23.5M | 1.75% | 460,008 -156 | -0% | -$7.95K |
|
|
17
Sarepta Therapeutics
SRPT
$1.78B
| $22.8M | 1.7% | +188,085 | New | +$22.8M |
|
18
Transmedics
TMDX
$3.92B
| $22.7M | 1.69% | 413,714 +46,083 | +13% | +$2.52M |
|
|
VRNA
19
Verona Pharma
VRNA
$9.16B
| $19M | 1.42% | 1,162,989 -366 | -0% | -$5.97K |
|
20
Celsius Holdings
CELH
$16.2B
| $17.9M | 1.33% | 104,094 -6,552 | -6% | -$1.12M |
|
|
21
BWX Technologies
BWXT
$14.8B
| $17.8M | 1.33% | +237,063 | New | +$17.8M |
|
22
Lantheus
LNTH
$3.73B
| $17.7M | 1.32% | 254,752 -15,017 | -6% | -$1.04M |
|
23
Exxon Mobil
XOM
$487B
| $17.7M | 1.32% | 150,500 -12,500 | -8% | -$1.47M |
|
|
ITCI
24
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $17.5M | 1.31% | 335,554 -163,949 | -33% | -$8.54M |
|
25
Lattice Semiconductor
LSCC
$9.09B
| $16.6M | 1.24% | 192,686 -662 | -0.3% | -$56.9K |
|